Objectives
Student learns to describe and understand the purpose of the different phases of the drug discovery and development process and discuss particular aspects of each stage of the process. Student can critically evaluate and select appropriate research methods to elucidate the pharmacological and pharmaceutical properties of drug molecules as well as to assess the toxicological and safety profiles of drug candidates during the various stages of non-clinical and clinical drug development. Furthermore, student understands the differences in drug development processes between "conventional" small molecule drugs, biologicals, and advanced therapy drugs, as well as biosimilars and generic drugs, which originate from differences in chemical, biological, and pharmacological properties and regulatory requirements. In addition, students can explain the role of intellectual property rights (IPR) in drug development and how this is reflected in the strategies of drug companies. Student understands the ethical guidelines that regulate the use of laboratory animals in research and clinical investigations. Student improves their skills in communication, scientific presenting, and team work by preparing presentations for Journal Clubs and podcasts as well as networking with external experts.
Student learns to describe and understand the purpose of the different phases of the drug discovery and development process and discuss particular aspects of each stage of the process. Student can critically evaluate and select appropriate research methods to elucidate the pharmacological and pharmaceutical properties of drug molecules as well as to assess the toxicological and safety profiles of drug candidates during the various stages of non-clinical and clinical drug development. Furthermore, student understands the differences in drug development processes between "conventional" small molecule drugs, biologicals, and advanced therapy drugs, as well as biosimilars and generic drugs, which originate from differences in chemical, biological, and pharmacological properties and regulatory requirements. In addition, students can explain the role of intellectual property rights (IPR) in drug development and how this is reflected in the strategies of drug companies. Student understands the ethical guidelines that regulate the use of laboratory animals in research and clinical investigations. Student improves their skills in communication, scientific presenting, and team work by preparing presentations for Journal Clubs and podcasts as well as networking with external experts.
- Teacher
Päivi Hirvensalo